Abbott Laboratories vs. Arcturus Therapeutics Holdings Inc. Common Stock
ABT
Abbott Laboratories
$115.51 +5.59%
VS ARCTArcturus Therapeutics Holdings Inc. Common Stock
$10.87 +13.94%
Abbott Laboratories and Arcturus Therapeutics Holdings Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | ARCT | |
|---|---|---|
| Market Cap | $189.30 billion | $271.16 million |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | ARCT | |
|---|---|---|
| Dividend Yield | 2.18% | — |
ABT and ARCT split the dividend factors evenly.
Risk & Sentiment
| ABT | ARCT | |
|---|---|---|
| Short Interest | 0.57% | 0.22% |
ARCT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, ARCT overview, ARCT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.